Hamed Abdollahpour | Biology and Life Sciences | Editorial Board Member

Published on by Research Hypothesis

Editorial Board Member

Hamed Abdollahpour is a researcher affiliated with the University of Guilan, Iran. His research profile is associated with Biology and Life Sciences. His publicly supplied Google Scholar profile reports bibliometric indicators that can be used to describe his scholarly output and citation activity. These indicators may change as publications are indexed and citations accumulate.

Hamed Abdollahpour
Affiliation University of Guilan
Country Iran
Scopus ID Not provided
Google Scholar ID 8OfGukwAAAAJ
Documents 35
Citations 347
h-index 10
Subject Area Biology and Life Sciences
Event International Research Hypothesis Excellence Award

Abstract

This article presents an academic recognition profile of Hamed Abdollahpour, a researcher affiliated with the University of Guilan in Iran. The profile summarizes the institutional affiliation, subject-area classification, and bibliometric figures supplied for his Google Scholar record. The reported figures are 35 documents, 347 citations, and an h-index of 10. These metrics provide a quantitative overview of indexed scholarly activity but do not, by themselves, establish research quality, originality, or practical significance. The profile is presented in the context of the International Research Hypothesis Excellence Award, with eligibility and recognition decisions subject to the event’s applicable criteria and independent verification of the candidate’s record.[1][2]

Keywords

Hamed Abdollahpour; University of Guilan; Iran; Biology and Life Sciences; scholarly publications; citation analysis; h-index; research profile; academic recognition; International Research Hypothesis Excellence Award.

Introduction

Academic research profiles bring together information about researchers, their institutional affiliations, publications, and citation records. They help readers locate scholarly work and assess the visibility of a researcher’s output within indexed literature. Google Scholar is one platform used to discover publications and review citation-related indicators, although its coverage and author attribution may vary across disciplines and records.[1]

This profile identifies Hamed Abdollahpour with the University of Guilan in Iran and classifies the stated subject area as Biology and Life Sciences. The information provided does not include a verified curriculum vitae, a complete publication list, a confirmed Scopus author identifier, or an ORCID identifier. Accordingly, this article distinguishes supplied profile data from information that requires further independent confirmation.

Research Profile

Hamed Abdollahpour is identified as being affiliated with the University of Guilan. His profile has been categorized under Biology and Life Sciences for the purposes of this recognition page. A more detailed account of his research specialization, academic qualifications, professional appointments, and laboratory or departmental affiliations would require corroborating institutional or scholarly sources.

The supplied Google Scholar profile is the primary public research-profile link associated with this article. Readers should consult the live record to review indexed works and current citation indicators, while checking individual publications to confirm authorship and bibliographic details.[1]

The indicators in this table reflect the information supplied for the profile and should be rechecked against the live author record before formal publication or award assessment. They are not independently certified measurements as of the date of this article.

Research Contributions

The assessment of a researcher’s contributions normally considers the originality of research questions, methodological rigor, reproducibility, scholarly dissemination, and relevance to the broader scientific community. For a profile in Biology and Life Sciences, relevant evidence may include peer-reviewed studies, validated experimental or analytical methods, contributions to biological knowledge, and work that supports further investigation.

The information available for this page does not identify specific research findings or establish which scientific advances should be attributed to Hamed Abdollahpour. Consequently, no particular discovery, method, or applied outcome is claimed here. A reliable contribution summary should be developed from verified publications, article abstracts, full-text research where available, and evidence of the researcher’s role in each work.

Publications

The supplied profile information reports 35 documents. This figure should be interpreted as a reported profile count rather than a verified list of 35 distinct peer-reviewed articles. Scholarly profile databases can include different publication types and may contain duplicate entries, incomplete metadata, or works requiring author disambiguation. The live Google Scholar profile provides a starting point for identifying publications associated with the researcher.[1]

Individual publications should be recorded using their full titles, author lists, journal or conference names, publication years, volume and page information where applicable, and DOI identifiers when assigned. Crossref provides a searchable bibliographic metadata service that can help verify DOI-linked publication records.[3]

No individual publication titles or DOIs were supplied for this profile. To avoid misattribution, the article does not invent a publication list or attach unrelated DOI links to the researcher.

Research Impact

The supplied bibliometric figures are 347 citations and an h-index of 10. The h-index is a combined measure of publication output and citation frequency: a researcher has an h-index of 10 when at least 10 publications have each received at least 10 citations, subject to the database and record used for calculation.[2]

Citation totals can provide a useful indication of scholarly visibility, but comparisons between researchers require care. Citation practices differ between disciplines, career stages, publication types, and databases. The metrics also do not directly measure the validity of findings, societal benefit, methodological quality, or the extent of an individual’s contribution to collaborative work.

A balanced impact assessment should therefore combine quantitative indicators with qualitative review of selected publications, research originality, methodological strength, reproducibility, collaboration, and documented academic or practical outcomes. Any formal assessment should state the data source and date on which the metrics were retrieved.

Award Suitability

The International Research Hypothesis Excellence Award is the recognition event named for this profile. The reported subject area, Biology and Life Sciences, provides a potential disciplinary context for consideration if it aligns with the award’s current categories and eligibility rules.

The supplied bibliometric indicators may form part of a candidate’s research record, but they are not sufficient on their own to establish eligibility, nomination status, selection, or receipt of an award. A fair assessment would require the applicable award criteria, a verified publication record, supporting documentation, and review of the originality and significance of the candidate’s work.

This article identifies the award associated with the page but does not assert that Hamed Abdollahpour has been nominated, shortlisted, selected, or formally recognized as a recipient. Those claims should be included only when supported by an official announcement or verifiable award documentation.

Conclusion

Hamed Abdollahpour is presented in this academic profile as a researcher affiliated with the University of Guilan in Iran, with a stated subject-area classification of Biology and Life Sciences. The supplied profile data reports 35 documents, 347 citations, and an h-index of 10. These figures offer a preliminary bibliometric snapshot, while further verification is needed to establish the detailed publication record, research contributions, identifiers, and current metrics. Any academic recognition assessment should combine reliable bibliographic evidence with a transparent qualitative evaluation of research quality and impact.

References

  1. Google Scholar. (n.d.). Hamed Abdollahpour: Author profile and scholarly citation information. Google Scholar. Profile details and bibliometric figures should be checked against the live record.
    https://scholar.google.com/citations?user=8OfGukwAAAAJ&hl=en
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    DOI: https://doi.org/10.1073/pnas.0507655102
  3. Crossref. (n.d.). Search metadata for scholarly publications and DOI records. Crossref.
    https://search.crossref.org/
  4. International Research Hypothesis Excellence Award. (n.d.). Official website. Research Hypothesis. Award categories, requirements, and recognition information should be confirmed using the current official event information.
    https://researchhypothesis.com/

Antonella Smeriglio | Biology | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Antonella Smeriglio
The University of Messina, Italy

Antonella Smeriglio
Affiliation The University of Messina
Country Italy
Scopus ID 55795057000
Documents 141
Citations 6,414
h-index 40
Subject Area Biology
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-9756-304X

Antonella Smeriglio is a researcher and academic affiliated with the University of Messina in Italy whose work is situated principally within pharmaceutical biology, pharmacognosy, phytochemistry, natural products, and the biological evaluation of plant-derived compounds. University and researcher-profile sources describe research activities involving the chemical characterization of plant extracts and bioactive constituents together with antioxidant, anti-inflammatory, cytoprotective, anti-melanogenic, anti-angiogenic, and antimicrobial investigations. [1]

Abstract

The Innovative Research Award profile recognizes scholarly activity characterized by sustained investigation, methodological development, and contributions to the understanding of biologically active natural products. Antonella Smeriglio’s documented research at the University of Messina encompasses pharmaceutical biology and pharmacognosy, with particular attention to phytochemical characterization and the biological properties of plant-derived materials. [1]Β [2]

Keywords

Antonella Smeriglio; Innovative Research Award; University of Messina; pharmaceutical biology; pharmacognosy; phytochemistry; natural products; plant bioactive compounds; antioxidant activity; nutraceutical research; biological evaluation; research innovation.

Introduction

Research in pharmaceutical biology frequently connects the characterization of natural substances with experimental assessment of their biological effects. Within this broad field, Smeriglio’s research has focused on plant-derived extracts and isolated compounds, combining analytical approaches with cell-free, cell-based, and in vivo models. The University of Messina profile describes experience in liquid and gas chromatography, mass spectrometry, atomic absorption methods, and biological assays used to investigate properties of natural substances. [1][2]

Research Profile

Smeriglio is associated with the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences at the University of Messina. The university profile identifies her research area with pharmaceutical biology and describes research lines involving phytochemical characterization and biological evaluation of plant extracts and their bioactive constituents. [1]

Independent scholarly profiles likewise associate her with pharmaceutical biology, natural product chemistry, phytochemicals, herbal medicine, pharmacology, antioxidants, polyphenols, and flavonoids. [3] Her ORCID record provides an additional persistent identifier and confirms the association between her researcher identity and Scopus Author ID 55795057000. [2]

Research Contributions

A central feature of Smeriglio’s research is the investigation of natural materials as sources of biologically relevant compounds. Her documented work examines chemical composition alongside activities such as antioxidant, cytoprotective, anti-inflammatory, anti-angiogenic, antimicrobial, and related biological effects. [1] [2]

Publications

The available scholarly records show a broad publication portfolio. The following examples illustrate representative themes rather than constituting a complete bibliography. Current indexing records may differ in document counts and citation metrics as databases are updated. [2]

Research Impact

The supplied recognition data attribute 141 documents, 6,414 citations, and an h-index of 40 to the researcher. These values should be understood as database-dependent indicators rather than fixed measures of scientific quality, because bibliometric databases are continuously updated and can report different counts at different times. For comparison, the currently accessible ScienceDirect author record associated with Scopus ID 55795057000 reports 135 documents, 5,851 citations, and an h-index of 37, demonstrating the importance of recording the source and date when presenting bibliometric metrics.[1]

Award Suitability

For the International Research Hypothesis Excellence Award, the supplied profile presents several characteristics that are relevant to an evaluation under an innovative research category. These include sustained publication activity, research spanning multiple related disciplines, development and application of analytical methodologies, and experimental investigation of biologically active natural substances. The documented institutional and ORCID records provide independently traceable information about the researcher’s academic identity and scholarly activity. [1] [2]

Conclusion

Antonella Smeriglio’s research profile reflects sustained scholarly engagement in pharmaceutical biology, pharmacognosy, phytochemistry, and the investigation of natural products. Her work combines analytical characterization with biological testing and encompasses research questions related to antioxidant, cytoprotective, anti-inflammatory, antimicrobial, nutraceutical, and other biologically relevant properties of natural substances. [1]

References

  1. UniversitΓ  degli Studi di Messina. (n.d.). Antonella Smeriglio β€” Research profile and institutional information. University of Messina.
    https://unime.unifind.cineca.it/get/person/030010
  2. ORCID. (n.d.). Antonella Smeriglio,ORCID.
    https://orcid.org/0000-0002-9756-304X
  3. ResearchGate. (n.d.). Antonella Smeriglio β€” University of Messina research profile.
    https://www.researchgate.net/profile/Antonella-Smeriglio
  4. Smeriglio, A., Bonasera, S., Monforte, M. T., Galati, E. M., & Trombetta, D. (2019). Opuntia ficus-indica (L.) Mill. fruit as source of betalains with antioxidant, cytoprotective, and anti-angiogenic properties. Phytotherapy Research. DOI: 10.1002/ptr.6345.
    https://doi.org/10.1002/ptr.6345
  5. Smeriglio, A., et al. (2023). Synergistic Combination of Citrus Flavanones as Strong Antioxidant and COX-Inhibitor Agent. Antioxidants, 12(4), 972. DOI: 10.3390/antiox12040972.
    https://doi.org/10.3390/antiox12040972

Zishan Jiao | Biology | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Zishan Jiao

Nutrition & Health Research Institute

Β  Β  Β  Β  Β  Β  Β  Β  Β Zishan Jiao
Affiliation Nutrition & Health Research Institute
Country China
Scopus ID 57815666000
Documents 7
Citations 67
h-index 4
Subject Area Biology
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-4832-291X

Zishan JiaoΒ the Innovative Research Award profile highlights the scholarly contributions and research accomplishments of Zishan Jiao, a researcher affiliated with the Nutrition & Health Research Institute in China. Through contributions to biological sciences and health-related research, the researcher has established a developing academic profile supported by peer-reviewed publications, scholarly citations, and measurable research impact. The recognition associated with the International Research Hypothesis Excellence Award reflects academic engagement, publication activity, and ongoing contributions to scientific knowledge dissemination.[1]

Abstract

This article presents an overview of the academic profile, research achievements, and scholarly significance of Zishan Jiao. The profile demonstrates engagement in biological research, publication of scientific findings, and participation in the advancement of knowledge relevant to nutrition and health sciences. Metrics including publication count, citation performance, and h-index provide evidence of scholarly visibility and impact within the academic community.[1][2]

Keywords

Biology, Nutrition Research, Health Sciences, Scientific Publications, Citation Analysis, Research Excellence, Academic Impact, Scholarly Communication, Research Recognition, Innovative Research Award.

Introduction

Academic recognition programs frequently evaluate researchers according to publication quality, citation influence, interdisciplinary relevance, and contributions to scientific advancement. Researchers working in biology and health sciences play a vital role in generating evidence-based knowledge that informs future studies, public health initiatives, and scientific innovation. Within this context, Zishan Jiao’s scholarly profile reflects meaningful participation in research activities associated with nutrition and health-related biological investigations.[1]

Research Profile

Zishan Jiao is affiliated with the Nutrition & Health Research Institute in China and has established a documented research presence within the biological sciences. The available scholarly indicators include seven indexed publications, sixty-seven citations, and an h-index of four. These metrics suggest that the researcher’s work has achieved measurable academic engagement and has been referenced by subsequent studies within related scientific domains.[1]

Research Contributions

The research activities associated with Zishan Jiao contribute to the broader fields of nutrition, biological sciences, and health-related investigations. Such contributions support scientific understanding of biological processes and provide foundations for future experimental and applied research. Scholarly outputs have contributed to ongoing discussions within relevant academic communities and have generated measurable citation activity.[1][3]

Publications

The publication portfolio indexed under the researcher’s Scopus profile consists of scholarly works addressing topics relevant to biology, nutrition, and health sciences. The body of work has accumulated citations from the wider academic community, indicating visibility and relevance. Publication quality and citation performance remain important indicators for evaluating scientific contribution and research influence.[1]

Research Impact

Research impact is commonly evaluated through indicators such as citation counts, publication visibility, author-level metrics, and academic engagement. With sixty-seven citations and an h-index of four, the available metrics indicate that multiple publications have received attention from fellow researchers and have contributed to the scholarly conversation within relevant fields.[1][2]

Award Suitability

The academic profile of Zishan Jiao demonstrates characteristics commonly associated with research recognition programs, including documented publication activity, citation performance, professional research affiliations, and contributions to biological sciences. The combination of scholarly output and measurable impact supports consideration for recognition through the International Research Hypothesis Excellence Award, which acknowledges ongoing commitment to scientific advancement and research excellence.[4]

Conclusion

Zishan Jiao’s research profile reflects active participation in biological and health-related scientific research. Through scholarly publications, citation impact, and institutional affiliation, the researcher contributes to the advancement of knowledge within the broader scientific community. The documented academic achievements provide a strong foundation for professional recognition and continued scholarly development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zishan Jiao, Author ID 57815666000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57815666000
  2. ORCID. (n.d.). ORCID record for Zishan Jiao.
    https://orcid.org/0000-0002-4832-291X
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.
  4. Research Hypothesis. (n.d.). International Research Hypothesis Excellence Award.
    https://researchhypothesis.com/
  5. Jiao, Z., Huang, J., Yang, J., Chen, X., & Zheng, X. (2026). Safety assessment of Aspergillus cristatus CCNH008 for potential use in food and health applications.

Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Dr. Viviana De Luca | Biology and Life Sciences | Research fellow at University of Sannio RCOST | Italy

Dr. Viviana De Luca is a distinguished researcher in biological, environmental, and health sciences, recognized for her advanced expertise in enzymology, carbonic anhydrase biology, antimicrobial drug discovery, and translational biomedical research. Her education encompasses advanced doctoral training in biology and environmental and health sciences, earned from leading Italian universities, with research conducted at prominent national research institutes specializing in biosciences, protein biochemistry, and molecular technologies. She has authored 108 documents, received 3,717 citations, and holds a 39 h-index, underscoring her strong scientific influence and consistent contributions to peer-reviewed literature indexed in major international databases such as Scopus.

Citation Metrics (Scopus)

5000

4000

3000

2000

1000

0

Citations
3,717

Documents
108

h-index
39

🟦 CitationsΒ  Β  Β  Β  πŸŸ₯ DocumentsΒ  Β   🟩 h-index

View Scopus Profile

Featured Publications

Production, crystallographic studies, and functional profiling of Ξ³-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insights – European Journal of Medicinal Chemistry

Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases – Archiv der Pharmazie

Coumarin-Containing Aromatic Sulfonamides With Carbonic Anhydrase Inhibitory Properties Against Human and Fungal Isoforms – Chemical Biology and Drug Design

Eco-Friendly Synthesis of Chitosan–Fatty Acid Nano Micelles and Their Differential Antibacterial Activity Against Escherichia coli and Bacillus subtilis – Journal of Functional Biomaterials

Acetazolamide-Loaded Nanoparticle Based on Modified Hyaluronic Acid as Delivery System to Target Carbonic Anhydrases in Escherichia coli – International Journal of Molecular Sciences

Shouping Xu | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Medical Physicist | Cancer Hospital Chinese Academy of Medical Sciences | China

Assoc. Prof. Dr. Shouping Xu is a distinguished medical physicist specializing in radiation oncology, with extensive expertise in advanced radiotherapy techniques and the integration of artificial intelligence in cancer treatment. He holds degrees in nuclear physics and medical physics from leading Chinese institutions and has served in senior leadership roles as Chief Clinical Medical Physicist at the Cancer Hospital, Chinese Academy of Medical Sciences, and previously at the Chinese PLA General Hospital and Yi Zhou Proton Therapy Center. Assoc. Prof. Dr. Shouping XuΒ  has made significant contributions to the development of innovative dose prediction models, proton therapy planning, and image-guided radiotherapy, with numerous publications in high-impact international journals. His active engagement in global conferences, memberships in professional societies, and certifications from recognized boards reflect his commitment to advancing medical physics. Widely respected for both his clinical leadership and research excellence, Assoc. Prof. Dr. Shouping Xu continues to play a key role in shaping the future of precision radiotherapy and medical imaging technologies.

Professional ProfileΒ 

EducationΒ Β 

Assoc. Prof. Dr. Shouping Xu has a strong academic background in physics and medical physics, beginning with a Bachelor of Science degree in Nuclear Physics Technology from Lanzhou University, China. He went on to pursue advanced studies at Tsinghua University, where he earned a Master of Science degree in Medical Physics from the Department of Engineering Physics, followed by a Doctor of Philosophy in Medical Physics from the same department. His education provided a solid foundation in radiation physics, imaging, and advanced treatment technologies, which has been central to his career in radiation oncology and his contributions to clinical innovation and research in medical physics.

Professional Experience

Assoc. Prof. Dr. Shouping Xu has built an extensive professional career in medical physics, holding key clinical and leadership positions in some of China’s most renowned cancer treatment centers. He currently serves as Chief Clinical Medical Physicist at the Proton Center of the Cancer Hospital, Chinese Academy of Medical Sciences, where he oversees clinical operations, quality management, and research in advanced radiotherapy. Previously, he was Chief Medical Physicist and Vice Director at the Yi Zhou Proton Therapy Center, where he played a pivotal role in establishing clinical workflows and implementing cutting-edge proton and photon therapies. Earlier in his career, he served at the Chinese PLA General Hospital as Chief and Senior Medical Physicist, contributing to innovations in IMRT, image-guided radiotherapy, and quality assurance. With responsibilities ranging from managing multidisciplinary teams to developing clinical protocols and engaging in pioneering research, Assoc. Prof. Dr. Shouping Xu has consistently demonstrated leadership, technical expertise, and a strong commitment to advancing radiation oncology practices.

Research Interest

Assoc. Prof. Dr. Shouping Xu’s research interests lie at the intersection of medical physics, radiation oncology, and artificial intelligence, with a focus on advancing precision radiotherapy. His work emphasizes the development of AI-driven algorithms and deep learning models for dose prediction, treatment planning, and image-guided radiotherapy, aiming to improve both the efficiency and accuracy of cancer treatment. He has conducted extensive studies on proton therapy, CyberKnife radiosurgery, and advanced techniques such as VMAT, IMRT, and adaptive radiotherapy, contributing to innovations in treatment optimization and quality assurance. Additionally, his research explores deformable image registration, dose verification, and the clinical application of AI for enhancing radiotherapy workflows. By bridging physics, engineering, and oncology, Assoc. Prof. Dr. Shouping Xu is committed to translating cutting-edge technologies into practical clinical tools that improve outcomes and safety for cancer patients.

Award and Honor

Assoc. Prof. Dr. Shouping Xu has earned recognition for his significant contributions to medical physics and radiation oncology through his active involvement in international conferences, professional societies, and research achievements. He has been an invited speaker and presenter at prestigious forums such as the AAPM Annual Meetings, the IUPESM World Congress on Medical Physics and Biomedical Engineering, and the Asia-Oceania Congress of Medical Physics, where his work on advanced radiotherapy techniques and AI-driven innovations has been highlighted. His leadership roles as Chief Clinical Medical Physicist and his certifications from the Chinese Board of Medical Physicists (CBMP) and the Chinese Board of Radiation Protection (CBRP) further underscore his professional excellence. Through his research, publications, and professional service, Assoc. Prof. Dr. Shouping Xu has gained both national and international recognition, reflecting his status as a highly respected figure in the field of medical physics.

Publications Top Noted

Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Year: 2025

Virtual-simulation boosted neural network dose calculation engine for intensity-modulated radiation therapy
Year: 2025

Dose rate correction of a diode array for universal wedge field dosimetric verification
Year: 2025

gMCAP: a GPU-based Monte Carlo proton transport program for high-density tissues with precise nuclear reaction models
Year: 2025

An AI dose-influence matrix engine for robust pencil beam scanning protons therapy
Year: 2025

A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Year: 2025

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance
Year: 2025

Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations
Year: 2024

Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis
Year: 2024

Conclusion

Assoc. Prof. Dr. Shouping Xu is highly suitable for the Best Researcher Award. His combination of clinical leadership, innovative research in AI-driven radiation therapy, and active participation in international scientific forums positions him as a thought leader in medical physics and oncology. With his strong portfolio of publications and pioneering approaches to radiation therapy planning and quality assurance, he demonstrates both scientific excellence and clinical relevance. With further emphasis on international collaborations and translational outcomes, his contributions will continue to shape the future of precision radiotherapy.

khosrow khalifeh | Biotechnology | Best Researcher Award

Published on by Research Hypothesis

khosrow khalifeh | Biotechnology | Best Researcher Award

Assoc. Prof. Dr khosrow khalifeh, University of Zanjan, Iran

Assoc. Prof. Dr. Khosrow Khalifeh is a leading Iranian biophysicist whose academic journey and research excellence have significantly advanced the fields of protein folding, bioinformatics, and molecular biophysics. Currently serving at the University of Zanjan, he specializes in investigating the structural dynamics of biomolecules and their functional interactions using experimental and computational approaches. His multidisciplinary teaching spans biophysical chemistry, radiation biology, and computational molecular biology. Dr. Khalifeh has authored several impactful publications in peer-reviewed journals and contributed chapters to prestigious Elsevier volumes. He is also known for pioneering work on luciferase proteins, chondroitinase enzymes, and the computational analysis of photoproteins. With over a decade of academic and research experience, his work not only enhances scientific understanding but also holds promise in areas like neurobiology and drug resistance. Dr. Khalifeh stands out as a deserving nominee for the Best Researcher Award due to his scholarly contributions, innovation, and commitment to education.

Publication Profile

Google Scholar

Education

Dr. Khosrow Khalifeh’s academic foundation is deeply rooted in the biological sciences and biophysics. He earned his Ph.D. in Biophysics from Tarbiat Modarres University, Tehran, in 2010. His doctoral research focused on the kinetic and thermodynamic behavior of wild-type and mutant Firefly Luciferase (Lampyris turkestanicus), exploring the complexities of protein folding and unfolding. He obtained his Master’s degree in Biophysics from the same institution in 2005, working on chemical modification of lysozyme and its impact on protein refolding kinetics. Prior to that, he completed his Bachelor of Science in Biology from Shahid Chamran University, Ahvaz, in 2000. His educational journey, characterized by strong theoretical and practical engagement with protein chemistry, molecular interactions, and biophysical mechanisms, has laid a solid groundwork for his later work in advanced biomolecular research and computational biology.

Experience

Dr. Khalifeh began his academic career as an Assistant Professor of Biophysics at the University of Zanjan in 2010. Over the next seven years, he actively contributed to teaching and research in molecular biophysics, eventually being promoted to Associate Professor in 2017. His teaching portfolio is extensive, including courses such as Biophysical Chemistry, Molecular Biophysics, Radiation Biophysics, Bioinformatics, and Biological Sequence Analysis. He also covers advanced topics like computational molecular biology and the philosophy of biology. Throughout his tenure, his teaching evaluations have consistently exceeded expectations, reflecting his commitment to academic excellence. His research integrates experimental biophysics and computational simulations, mentoring numerous graduate students while collaborating with national and international researchers. Dr. Khalifeh has built a reputation for combining innovative methodologies with solid pedagogical skills, and his ongoing efforts continue to shape the next generation of biophysicists in Iran and beyond.

Awards and Honors

Although specific awards and honors are not listed in the provided data, Assoc. Prof. Dr. Khosrow Khalifeh’s distinguished academic trajectory and peer recognition can be inferred from his consistently high teaching evaluations, publication record, and contributions to edited volumes by Academic Press (Elsevier). His selection as a co-author for high-impact book chapters such as β€œSpectroscopic Methods to Study Protein Folding Kinetics” and β€œChondroitinase ABC I in Spinal Cord Injury” speaks volumes about his expertise and scientific standing. Dr. Khalifeh’s work has been published in reputable journals like International Journal of Biological Macromolecules, Spectrochimica Acta, Luminescence, European Biophysics Journal, and Scientific Reports. These accomplishments reflect peer recognition and academic influence, establishing him as a key thought leader in his field. His eligibility for the Best Researcher Award is further strengthened by this solid academic footprint and the originality of his contributions to biophysical research.

Research Focus

Dr. Khosrow Khalifeh’s research spans the intersecting domains of biophysics, bioinformatics, systems biology, and biotechnology. His primary focus lies in understanding protein folding and unfolding mechanisms, enzyme dynamics, and molecular interactions using both wet-lab experiments and in silico simulations. He has significantly contributed to the molecular study of photoproteins such as Mnemiopsin and enzymes like Chondroitinase ABC I and cyclomaltodextrinase. His research employs molecular dynamics simulations, structural modeling, and thermodynamic profiling to explore the functional consequences of site-directed mutations and ligand binding. Additionally, he has investigated protein-DNA interactions, protein engineering, and the biochemical effects of mutation-induced charge shifts, offering insights into disease-related protein dysfunctions and potential biotechnological applications. This cross-disciplinary focus positions Dr. Khalifeh at the cutting edge of biomolecular and computational biophysics, making his work highly impactful for both theoretical understanding and translational science.

Publication Top Notes

Interaction of lysozyme with gold nanorods: conformation and activity investigations

Roles of trehalose and magnesium sulfate on structural and functional stability of firefly luciferase

Thermodynamics of protein folding: methodology, data analysis and interpretation of data

Effect of arginine on pre-nucleus stage of interferon beta-1b aggregation

Critical role of a loop at C-terminal domain on the conformational stability and catalytic efficiency of chondroitinase ABC I

OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells

The role of trehalose for metastable state and functional form of recombinant interferon beta-1b

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Published on by Research Hypothesis

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. πŸ–πŸ“ˆ Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. πŸ‡³πŸ‡΄πŸ”¬ He also serves part-time as a church servant at Uranienborg Menighet since 2020. β›ͺ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). πŸ›‘οΈπŸ₯ With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. πŸŽ“πŸŒ His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. πŸ¦ πŸ“– A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. πŸ†βœ¨

PublicationΒ  Profile

Orcid

EducationΒ 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. πŸŽ“πŸΎ He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. πŸ‡³πŸ‡΄πŸ“š He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. πŸ‡ΊπŸ‡ΈπŸ“Š Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. πŸ‡¦πŸ‡ΊπŸ©Ί His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. πŸ…πŸŒŸ

ExperienceΒ 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. πŸ·πŸ“Š In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. β›ͺ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. πŸ”πŸ” He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). πŸŽ–οΈπŸš› These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. πŸ…πŸ“ˆ

Awards and HonorsΒ 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. πŸΎπŸ“ˆ His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. πŸ¦ πŸ”¬ His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. πŸ‡³πŸ‡΄πŸ– Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. πŸŽ–οΈπŸŒ Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. πŸ…πŸ“š His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research FocusΒ 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. πŸ–πŸ¦  His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. πŸ“ŠπŸ›‘οΈ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. πŸ“ˆπŸ–₯️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. πŸ§¬πŸ” Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. πŸ“‘πŸ“ˆ His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. πŸ†πŸ”¬ His work supports healthier livestock systems and contributes to global food security. πŸŒπŸ–

Publications Top Notes

  • πŸ“„ “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • πŸ“„ “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • πŸ“„ “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • πŸ“„ “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • πŸ“„ “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • πŸ“„ “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Graciela Castro Escarpulli | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Graciela Castro Escarpulli | Biology and Life Sciences | Best Researcher Award

Prof. Dr Graciela Castro Escarpulli, Escuela Nacional de Ciencias BiolΓ³gicas IPN, Mexico

Prof. Dr. Graciela Castro Escarpulli is a renowned professor and researcher at the National School of Biological Sciences, IPN, specializing in Medical Bacteriology and Molecular Biomedicine. She leads multiple research lines using conventional and molecular methods to identify infectious bacteria. With 145 undergraduate theses, 44 master’s, and 18 doctoral theses directed, her contributions include 114 publications, 33 book chapters, and 342 conference presentations. A pioneer in CRISPR-Cas for bacterial typing, she has received numerous awards, including the IPN Research Award and the LΓ‘zaro CΓ‘rdenas Medal. She is a member of the National System of Researchers (Level 2) since 2006. πŸ§¬πŸ”¬πŸ“šπŸ…

Publication Profile

Orcid

Academic & Research Background

Prof. Dr. Graciela Castro Escarpulli is a distinguished professor and researcher at the National School of Biological Sciences, IPN. With expertise in diagnostic medical bacteriology and molecular biomedicine, she has significantly contributed to the field. Her research focuses on both conventional and molecular methods for identifying bacteria responsible for infectious diseases. Through her leadership, she has driven various research lines, advancing diagnostic techniques and improving public health outcomes. Prof. Dr. Castro Escarpulli’s work continues to have a profound impact on medical microbiology, enhancing our understanding of bacterial infections. πŸ§¬πŸ”¬πŸ¦ πŸ‘©β€πŸ”¬

Achievements & RecognitionΒ 

Prof. Dr. Graciela Castro Escarpulli is an accomplished academic with an impressive track record. She has supervised 145 bachelor’s theses, 44 master’s theses, and 18 doctoral theses. With 114 indexed papers, 33 book chapters, and 342 global presentations, her expertise spans multiple disciplines. Prof. Castro Escarpulli holds one international patent and has 849 sequences deposited in NCBI, showcasing her contributions to scientific research. Her work continues to make a significant impact in her field, both through academic achievements and innovation. πŸ“šπŸŽ“πŸŒπŸ§¬πŸ”¬πŸ“‘

Awards & ContributionsΒ 

Prof. Dr. Graciela Castro Escarpulli is a renowned researcher and a pioneer in using the CRISPR-Cas system for bacterial typing. She has received several prestigious awards, including the IPN Research Award, the National Technological Innovation Award, and the LΓ‘zaro CΓ‘rdenas Medal πŸ…. Dr. Castro Escarpulli is highly regarded for her contributions to microbiology and biotechnology 🌱. As a frequent speaker at global conferences 🌍, she continues to influence scientific advancements in her field. Her work exemplifies innovation and dedication to improving scientific understanding, particularly in microbial genetics 🧬.

Research Focus

Prof. Dr. Graciela Castro Escarpulli’s research focuses on microbiology, particularly infectious diseases, and the study of pathogens through advanced genetic analysis techniques. Her work includes the use of massive sequencing to identify unusual bacteria in pyogenic liver abscesses, which may not be detected by classical culture methods. She also explores the genetic makeup of pathogens like Acinetobacter baumannii and Candida spp., as well as antimicrobial resistance in Escherichia coli. Her studies contribute to understanding disease mechanisms, improving diagnostics, and combating antimicrobial resistance. πŸ”¬πŸ¦ πŸ’‰πŸ§¬

Publication Top Notes

Massive Sequencing of V3-V4 Hypervariable Region in Pyogenic Liver Abscesses Reveals the Presence of Unusual Bacteria Not Detected by Classical Culture Methods

Multidisciplinary Approach of a Male Case of Imported Malaria, HIV Chronic Infection, and Latent Syphilis

Comprehensive comparative analysis of the periodontal pathogen Porphyromonas gingivalis: exploring the pan-genome, the reconstruction of the gene regulatory network and genome-scale metabolic network

The CRISPR–Cas system in clinical strains of Acinetobacter baumannii: an in-silico analysis

Typing of Candida spp. from Colonized COVID-19 Patients Reveal Virulent Genetic Backgrounds and Clonal Dispersion

Genomic Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in Tamaulipas, Mexico

ESKAPE bacteria characterization reveals the presence of Acinetobacter baumannii and Pseudomonas aeruginosa outbreaks in COVID-19/VAP patients

Disinfection efficacy of ozone on ESKAPE bacteria biofilms: Potential use in difficult-to-access medical devices

Impact of the modification of a cleaning and disinfection method of mechanical ventilators of COVID-19 patients and ventilator-associated pneumonia: One year of experience

xuekun Zhang | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

xuekun Zhang | Biology and Life Sciences | Best Researcher Award

Prof xuekun Zhang, Shihezi University, China

Prof. Xuekun Zhang is an Associate Professor at Shihezi University, specializing in crop resistance/susceptibility genes and biological control of plant diseases 🌱🧬. He holds a doctoral degree from Huazhong Agricultural University and a master’s from Shihezi University. His research focuses on utilizing bioinformatics and molecular biology to identify key genes related to crop disease resistance, and studying pathogenic fungi for biocontrol potential πŸ¦ πŸ”¬. He has led multiple provincial and university-level projects and published over 20 papers, including in top journals like Viruses and Front Plant Sci πŸ“š. He also teaches advanced plant immunology and plant pathology courses πŸ“–.

Publication Profile

Scopus

Research Interests

Professor Xuekun Zhang specializes in the mining and utilization of crop resistance and susceptibility genes, aiming to enhance agricultural resilience. His research focuses on understanding plant responses to diseases and improving crop protection. He also investigates the biological control of plant diseases, employing natural mechanisms to reduce reliance on chemical treatments. His work aims to create sustainable agricultural practices, ensuring better crop yields and healthier ecosystems. Prof. Zhang’s expertise is integral in advancing crop science and plant pathology. πŸŒ±πŸŒΎπŸ”¬πŸ§¬πŸŒ

Experience

Prof. Xuekun Zhang holds a doctoral degree and serves as an associate professor and master’s thesis supervisor. He graduated with a master’s degree from Shihezi University in 2013 and worked at the Cotton Research Institute of Xinjiang Agricultural Reclamation Science Academy from 2013 to 2017. In 2021, he obtained his doctoral degree from Huazhong Agricultural University. Following this, he joined the College of Agriculture at Shihezi University, where he continues to contribute to academic research and mentoring. πŸŒ±πŸŽ“πŸ“šπŸŒΎ

Research Field

Prof. Xuekun Zhang specializes in bioinformatics and molecular biology to identify key genes linked to crop resistance and susceptibility to diseases. πŸŒ±πŸ”¬ He explores the mechanisms behind these genes’ actions and investigates harmful pathogenic fungi and viruses to find low-virulence strains with biocontrol potential. 🦠πŸ’ͺ Prof. Zhang has led three provincial-level scientific research projects and two university-level ones, contributing significantly to the field. He has also participated in three National Natural Science Foundation projects, the “Comprehensive Scientific Expedition to Xinjiang” by the National Ministry of Science and Technology, and several other national and regional research programs. πŸŒπŸ”

Research Achievements

Prof. Xuekun Zhang is an accomplished researcher with over 20 publications, including 12 SCI papers where he served as the first or corresponding author. His work has been featured in prestigious journals such as Plant Biotechnology Journal, Viruses, Plants, and Agronomy. Notably, one of his papers was published in a top-tier journal, and since 2019, he has consistently published papers with an impact factor (IF) greater than 7.0. His research contributions continue to advance the field, demonstrating his expertise and influence in plant biotechnology and related areas. πŸ“šπŸŒ±πŸ”¬πŸŒΏ

Research Focus

Prof. Xuekun Zhang’s research primarily focuses on plant-pathogen interactions, particularly in the context of parasitic plants like broomrape (Orobanche) and their impact on crop health. His work involves the identification and genetic diversity of broomrape species in Xinjiang, China, as well as exploring plant resistance mechanisms, such as jasmonate signaling pathways and cell wall activity, to combat parasitic infestation. Zhang also investigates the role of mycoviruses in pathogens affecting fragrant pears and cotton plants, aiming to develop better disease management strategies. His interdisciplinary studies incorporate molecular biology, genomics, and plant pathology. πŸŒ±πŸ”¬πŸ§¬πŸŒΎ

Publication Top Notes

Identification and genetic diversity analysis of broomrape in Xinjiang, China

Jasmonate ZIM Domain Protein (JAZ) Gene SLJAZ15 Increases Resistance to Orobanche aegyptiaca in Tomato

Integrated Transcriptome and Proteome Analysis Reveals That Cell Wall Activity Affects Phelipanche aegyptiaca Parasitism

Identification of Mycoviruses in the Pathogens of Fragrant Pear Valsa Canker from Xinjiang in China

MAPK and phenylpropanoid metabolism pathways involved in regulating the resistance of upland cotton plants to Verticillium dahliae

First Report of Karelinia caspia as a New Host of Orobanche cumana in Xinjiang, China

 

 

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. πŸŒŸπŸ“šπŸ’‰πŸ”¬πŸ§¬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. πŸ“šπŸ’‰πŸ”¬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. πŸ†πŸ”¬πŸŽ“

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 πŸ“š. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics πŸ§ͺ. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education πŸ’‘. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences πŸŽ“.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. πŸ“šπŸ’ŠπŸΎπŸ‘©β€πŸ”¬πŸ‘¨β€πŸ”¬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. πŸ”¬πŸ’‰πŸ§¬πŸ«€

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human VΞ³2VΞ΄2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated Ξ³/Ξ΄ T cell maturation of dendritic cells